Metformin powder formulation compared to metformin tablets on glycemic control and on treatment satisfaction in subjects with type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Metformin powder formulation compared to metformin tablets on glycemic control and on treatment satisfaction in subjects with type 2 diabetes mellitus

Published:2015-02-04 Issue:4 Volume:55 Page:409-414
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Derosa Giuseppe¹²,Romano Davide¹,Bianchi Lucio¹,D'Angelo Angela¹,Maffioli Pamela¹³

Affiliation:

1. Department of Internal Medicine and Therapeutics; University of Pavia and Fondazione IRCCS Policlinico S. Matteo; Pavia Italy

2. Center for the Study of Endocrine-Metabolic Pathophysiology and Clinical Research; University of Pavia; Pavia Italy

3. Phd School in Experimental Medicine; University of Pavia; Pavia Italy

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.415/fullpdf

Reference26 articles.

1. Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases;Cricelli;J Public Health Med,2003

2. http://infodiabetes.it/files/ANNALI2010.pdf

3. American Diabetes Association. Standards of Medical Care in Diabetes-2014;Diabetes Care,2014

4. Metformin: new understandings, new uses;Hundal;Drugs,2003

5. Metformin and its clinical use: new insights for an old drug in clinical practice;Cicero;Arch Med Sci,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factores asociados a la insatisfacción con el tratamiento farmacológico en pacientes con diabetes mellitus tipo 2: estudio transversal;Journal of Healthcare Quality Research;2023-03

2. Evaluation of Self-care Activities and Quality of Life in Patients With Type 2 Diabetes Treated With Metformin Using the 2D Matrix Code of Outer Drug Packages as Patient Identifier: the DePRO Proof-of-Concept Observational Study;JMIR Diabetes;2022-05-24

3. Evaluation of Self-care Activities and Quality of Life in Patients With Type 2 Diabetes Treated With Metformin Using the 2D Matrix Code of Outer Drug Packages as Patient Identifier: the DePRO Proof-of-Concept Observational Study (Preprint);2021-07-26

4. Metformin: From Immediate Release to Extended Release Formula, Effectiveness, And Safety in Patients With Chronic Kidney Disease;EMJ Diabetes;2020-11-10

5. Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes;Drug Design, Development and Therapy;2017-05